相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gellan gum-based delivery systems of therapeutic agents and cells
Fabio Salvatore Palumbo et al.
CARBOHYDRATE POLYMERS (2020)
In vitro-in vivo evaluation of tetrahydrozoline-loaded ocular in situ gels on rabbits for allergic conjunctivitis management
Neslihan Ustundag Okur et al.
DRUG DEVELOPMENT RESEARCH (2020)
Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route
Anindita Chowhan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Novel Ocular Drug Delivery Systems: An Update on Microemulsions
Neslihan Ustundag Okur et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2020)
Improving therapeutic efficacy of voriconazole against fungal keratitis: Thermo-sensitive in situ gels as ophthalmic drug carriers
Neslihan Ustundag Okur et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
Gellan Gum Based Sol-to-Gel Transforming System of Natamycin Transfersomes Improves Topical Ocular Delivery
Karthik Yadav Janga et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Role of CCL7 in Type I Hypersensitivity Reactions in Murine Experimental Allergic Conjunctivitis
Chuan-Hui Kuo et al.
JOURNAL OF IMMUNOLOGY (2017)
Down-Regulation of miR-146a Expression Induces Allergic Conjunctivitis in Mice by Increasing TSLP Level
Wen Sun et al.
MEDICAL SCIENCE MONITOR (2015)
In situ gel systems as 'smart' carriers for sustained ocular drug delivery
Ashish Kumar Agrawal et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
In-vitro and in-vivo evaluation of carrageenan/methylcellulose polymeric systems for transscleral delivery of macromolecules
T. R. Thrimawithana et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Sustained Ophthalmic In Situ Gel of Ketorolac Tromethamine: Rheology and In Vivo Studies
A. S. Manjappa et al.
DRUG DEVELOPMENT RESEARCH (2009)
In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate
Shi-lei Cao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats
K Minami et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
A comparative trial of the safety and efficacy of 0.1 percent pemirolast potassium ophthalmic solution dosed twice or four times a day in patients with seasonal allergic conjunctivitis
P Gous et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2004)
Stimuli-reponsive polymers and their bioconjugates
ES Gil et al.
PROGRESS IN POLYMER SCIENCE (2004)
Two mast cell stabilizers, pemirolast potassium 0.1% and nedocromil sodium 2%, in the treatment of seasonal allergic conjunctivitis: A comparative study
DG Shulman
ADVANCES IN THERAPY (2003)
Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: A pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies
MB Abelson et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2002)
Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system
B Srividya et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Carbopol/pluronic phase change solutions for ophthalmic drug delivery
HR Lin et al.
JOURNAL OF CONTROLLED RELEASE (2000)
分享论文
